CARsgen Therapeutics announces positive results from China GC/GEJ pivotal phase II trial of Claudin18.2 CAR-T: Shanghai, China Tuesday, December 31, 2024, 14:00 Hrs [IST] CARsgen ...
11hon MSN
We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...
NEW YORK – Carsgen Therapeutics on Monday said it plans to seek approval in China for its autologous CAR T-cell therapy satricabtagene autoleucel (satri-cel) in previously treated patients with ...
New York Judge Delays Start of Trial Between CFTC and Gemini Trust Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback